Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. WIN-Partners Co's Revenue for the
six
months ended in Mar. 2026 was 円46,653 Mil. WIN-Partners Co's average Accounts Receivable for the
six
months ended in Mar. 2026 was 円17,311 Mil.
Hence, WIN-Partners Co's Receivables Turnover for the
six
months ended in Mar. 2026 was 2.69.
WIN-Partners Co (TSE:3183) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
WIN-Partners Co Receivables Turnover Related Terms
WIN-Partners Co Receivables Turnover Historical Data
* Premium members only.
The historical data trend for WIN-Partners Co's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:3183 vs MCK, COR, CAH: Receivables Turnover Comparison
For the Medical Distribution subindustry, WIN-Partners Co's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
WIN-Partners Co Receivables Turnover vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, WIN-Partners Co's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where WIN-Partners Co's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WIN-Partners Co (TSE:3183) has a Receivables Turnover of 2.69 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on WIN-Partners Co and its competitors. According to the industry distribution chart, WIN-Partners Co ranks #51 out of 119 companies in the Medical Distribution industry, placing it in the top 42.9%.
Is WIN-Partners Co's Receivables Turnover too high?
WIN-Partners Co's current Receivables Turnover is 2.69. The Medical Distribution industry median Receivables Turnover is 4.55. WIN-Partners Co's value of 2.69 is 40.9% below this industry median. Based on the distribution chart, WIN-Partners Co ranks #51 out of 119 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, WIN-Partners Co has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does WIN-Partners Co's Receivables Turnover compare to MCK and COR?
According to the Medical Distribution industry distribution chart, WIN-Partners Co ranks #51 out of 119 companies for Receivables Turnover. This puts WIN-Partners Co in the upper half of its industry. The industry median Receivables Turnover is 4.55. WIN-Partners Co's value of 2.69 is 40.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Distribution company?
The median Receivables Turnover among Medical Distribution companies is 4.55, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. WIN-Partners Co's current Receivables Turnover of 2.69 is 40.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on WIN-Partners Co and its competitors. For the Medical Distribution industry, the median Receivables Turnover is 4.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. WIN-Partners Co's current Receivables Turnover is 2.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is WIN-Partners Co stock overvalued right now?
Based on GuruFocus' analysis, WIN-Partners Co (TSE:3183) is currently considered Modestly Undervalued. The stock's GF Value™ is 円1,530.83, compared to a current price of 円1,357.00 — trading 11.4% below its estimated fair value. The current Receivables Turnover is 2.69 and 40.9% below the Medical Distribution industry median of 4.55. WIN-Partners Co's overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For WIN-Partners Co (TSE:3183), the current Receivables Turnover is 2.69 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is WIN-Partners Co (TSE:3183) Overvalued in 2026?
Based on GuruFocus' analysis, WIN-Partners Co stock appears to be undervalued.
The current stock price of 円1,357.00 is trading 11.4% below its estimated GF Value™ of 円1,530.83.
GuruFocus considers WIN-Partners Co to be Modestly Undervalued.
Key valuation signals for TSE:3183:
Receivables Turnover: 2.69
GF Value™: 円1,530.83 vs. price of 円1,357.00 (11.4% below fair value)
Industry Position: 40.9% below the Medical Distribution median (#51 of 119)
No single metric tells the full story. See the TSE:3183 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
WIN-Partners Co Ltd is engaged in the healthcare sector. The company provides medical devices to Japan's medical institutions. Its products offerings are Cardiovascular device, Insulin Pump, X-ray Angio System, Carotid Artery Stent, Stent Graft, among others. The company operates only in one segment which is the medical equipment sales business.
67GF Score
Get the complete analysis for TSE:3183
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3183 has been successfully added to your 
